Clinical Trial: DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07358078) titled 'DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting' on Nov. 13, 2025.

Brief Summary: The purpose of this study is to:

* Describe the clinical characteristics of adult patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM) treated with vutrisiran in routine clinical care

* Describe treatment patterns of adult patients with ATTR-CM treated with vutrisiran in routine clinical care

* Assess health-related quality of life (HRQOL) in adult patients with ATTR-CM treated with vutrisiran in routine clinical care

* Assess healthcare resource use (HCR...